FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075045125> ?p ?o ?g. }

• W2075045125 endingPage "674" @default.
• W2075045125 startingPage "663" @default.
• W2075045125 abstract "1. Effects of 3 h infusions of adrenaline (0.4 nmol kg-1 min-1) or placebo and of mental stress evoked by a colour word test (CWT) on adrenergic receptor function were investigated in healthy men. Responses of heart rate, blood pressure, plasma catecholamines, plasma cyclic AMP and plasma free fatty acids (FFA) were evaluated during infusions and CWT. In vitro beta 2-adrenoceptor numbers [( 125I]-HYP binding) and function (isoprenaline induced cyclic AMP accumulation) were studied on lymphocytes in all experiments. alpha 2-adrenoceptor binding [( 3H]-yohimbine and adrenaline) to intact platelets was evaluated in the infusion experiments only. 2. Placebo infusion evoked no major alterations of any parameter. 3. Adrenaline infusion raised venous plasma adrenaline levels to 4-5 nmol l-1, increased heart rate by 14 +/- 3 beats min-1 and plasma cyclic AMP by 17 +/- 3 nmol l-1, and decreased diastolic blood pressure by 15 +/- 5 mm Hg. These responses persisted throughout the infusion. Plasma FFA levels, on the other hand, increased at 30 min of infusion (from 236 +/- 44 to 717 +/- 92 mumol l-1) and returned to basal levels after 3 h of infusion. 4. In vitro, lymphocytes showed increased beta 2-responsiveness after 30 min of adrenaline infusion (delta cyclic AMP increased from 1.86 +/- 0.24 to 3.06 +/- 0.58 pmol/10(6) cells), but a decreased response (0.47 +/- 0.10 pmol/10(6) cells) after 3 h of infusion. [125I]-HYP binding to lymphocyte membranes showed a three-fold increase of Bmax at 30 min of adrenaline infusion followed by a return to basal values after 3 h of infusion. [125I]-HYP binding reflected the functional responsiveness of the lymphocytes in vitro poorly. alpha 2-adrenoceptors on platelets were not altered with regard to Bmax or Kd for [3H]-yohimbine binding or Ki for adrenaline displacement of [3H]-yohimbine binding. 5. CWT evoked marked circulatory changes, a four-fold increase in plasma adrenaline and a 60% increase in beta 2-adrenoceptor binding sites without changes in functional responsiveness of the lymphocytes. 6. We conclude that exposure to high physiological levels of adrenaline in vivo alters lymphocyte beta-adrenoceptor responsiveness in a biphasic manner, with an early increase followed by a later decrease, but that most beta-adrenoceptor mediated responses to adrenaline in vivo remain intact. Lymphocyte alterations may reflect recruitment of cells into the circulation during sympathoadrenal stimulation. Platelet alpha 2-adrenoceptors are apparently not easily subjected to agonist induced dynamic receptor regulation.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2075045125 created "2016-06-24" @default.
• W2075045125 creator A5002513118 @default.
• W2075045125 creator A5068373464 @default.
• W2075045125 creator A5082279718 @default.
• W2075045125 creator A5089563207 @default.
• W2075045125 date "1989-12-01" @default.
• W2075045125 modified "2023-10-02" @default.
• W2075045125 title "Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues." @default.
• W2075045125 cites W1480109394 @default.
• W2075045125 cites W1550978342 @default.
• W2075045125 cites W1775749144 @default.
• W2075045125 cites W1950281501 @default.
• W2075045125 cites W1967325029 @default.
• W2075045125 cites W1977298101 @default.
• W2075045125 cites W1979083678 @default.
• W2075045125 cites W1992681890 @default.
• W2075045125 cites W1993508801 @default.
• W2075045125 cites W1997242520 @default.
• W2075045125 cites W1997594400 @default.
• W2075045125 cites W2026675160 @default.
• W2075045125 cites W2039849556 @default.
• W2075045125 cites W2042735062 @default.
• W2075045125 cites W2043813981 @default.
• W2075045125 cites W2062302096 @default.
• W2075045125 cites W2064099758 @default.
• W2075045125 cites W2066338041 @default.
• W2075045125 cites W2080473110 @default.
• W2075045125 cites W2082104338 @default.
• W2075045125 cites W2087973702 @default.
• W2075045125 cites W2109811381 @default.
• W2075045125 cites W2146907325 @default.
• W2075045125 cites W2147478901 @default.
• W2075045125 cites W2151556344 @default.
• W2075045125 cites W2152398565 @default.
• W2075045125 cites W2221112779 @default.
• W2075045125 cites W2278336196 @default.
• W2075045125 cites W2285903967 @default.
• W2075045125 cites W2343207233 @default.
• W2075045125 cites W2400201077 @default.
• W2075045125 cites W2404500559 @default.
• W2075045125 cites W2408373352 @default.
• W2075045125 cites W2415355820 @default.
• W2075045125 cites W2416423914 @default.
• W2075045125 cites W2475192110 @default.
• W2075045125 cites W3023253888 @default.
• W2075045125 doi "https://doi.org/10.1111/j.1365-2125.1989.tb03559.x" @default.
• W2075045125 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1380037" @default.
• W2075045125 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2558700" @default.
• W2075045125 hasPublicationYear "1989" @default.
• W2075045125 type Work @default.
• W2075045125 sameAs 2075045125 @default.
• W2075045125 citedByCount "19" @default.
• W2075045125 countsByYear W20750451252018 @default.
• W2075045125 crossrefType "journal-article" @default.
• W2075045125 hasAuthorship W2075045125A5002513118 @default.
• W2075045125 hasAuthorship W2075045125A5068373464 @default.
• W2075045125 hasAuthorship W2075045125A5082279718 @default.
• W2075045125 hasAuthorship W2075045125A5089563207 @default.
• W2075045125 hasBestOaLocation W20750451252 @default.
• W2075045125 hasConcept C126322002 @default.
• W2075045125 hasConcept C134018914 @default.
• W2075045125 hasConcept C170493617 @default.
• W2075045125 hasConcept C185592680 @default.
• W2075045125 hasConcept C24998067 @default.
• W2075045125 hasConcept C2775859304 @default.
• W2075045125 hasConcept C2775894120 @default.
• W2075045125 hasConcept C2776090920 @default.
• W2075045125 hasConcept C2776885963 @default.
• W2075045125 hasConcept C2777676773 @default.
• W2075045125 hasConcept C2777953023 @default.
• W2075045125 hasConcept C40465926 @default.
• W2075045125 hasConcept C71924100 @default.
• W2075045125 hasConcept C84393581 @default.
• W2075045125 hasConceptScore W2075045125C126322002 @default.
• W2075045125 hasConceptScore W2075045125C134018914 @default.
• W2075045125 hasConceptScore W2075045125C170493617 @default.
• W2075045125 hasConceptScore W2075045125C185592680 @default.
• W2075045125 hasConceptScore W2075045125C24998067 @default.
• W2075045125 hasConceptScore W2075045125C2775859304 @default.
• W2075045125 hasConceptScore W2075045125C2775894120 @default.
• W2075045125 hasConceptScore W2075045125C2776090920 @default.
• W2075045125 hasConceptScore W2075045125C2776885963 @default.
• W2075045125 hasConceptScore W2075045125C2777676773 @default.
• W2075045125 hasConceptScore W2075045125C2777953023 @default.
• W2075045125 hasConceptScore W2075045125C40465926 @default.
• W2075045125 hasConceptScore W2075045125C71924100 @default.
• W2075045125 hasConceptScore W2075045125C84393581 @default.
• W2075045125 hasIssue "6" @default.
• W2075045125 hasLocation W20750451251 @default.
• W2075045125 hasLocation W20750451252 @default.
• W2075045125 hasLocation W20750451253 @default.
• W2075045125 hasLocation W20750451254 @default.
• W2075045125 hasOpenAccess W2075045125 @default.
• W2075045125 hasPrimaryLocation W20750451251 @default.
• W2075045125 hasRelatedWork W1997270504 @default.
• W2075045125 hasRelatedWork W2004094643 @default.
• W2075045125 hasRelatedWork W2007057618 @default.

• next